{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:46:56Z","timestamp":1787784416305,"version":"build-2784847793"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T00:00:00Z","timestamp":1631318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>As we move toward human papillomavirus (HPV) only as the preferred cervical cancer screening method, we performed a retrospective analysis of Black and White women with negative cytology (Papanicolaou negative [PAPneg]) and positive high-risk HPV (hrHPV) (HPVpos) results and determined follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched our pathology data system for patients with PAPneg\/HPVpos results (2017-2019). Follow-up data were reviewed (39 months), and a comparison among race was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 1,728 patients were identified (Black, 53%; White, 47%). Twenty-nine percent of the patients had no follow-up with no difference among the races. HPV 16 was more common among Whites (P\u2005&amp;lt;\u2005.01), while non-16\/18 hrHPV was more common among Black patients (P\u2005=\u2005.01). A total of 30 (3.3%) Black and 26 (3.2%) White patients were diagnosed with cervical intraepithelial neoplasia grade 2\/3 (CIN 2\/3). More White women were diagnosed on biopsy alone (negative endocervical curettage) compared with Black women (20 vs 9, P\u2005&amp;lt;\u2005.01). Meanwhile, there were 21 Black and 6 White women with CIN 2\/3 on endocervical curettage (P\u2005=\u2005.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Follow-up of women with PAPneg\/HPVpos remains a challenge. There was no disparity in follow-up when cohorts were compared. However, Black women had higher numbers of high-grade intraepithelial lesions on endocervical curettage.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqab129","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T19:06:56Z","timestamp":1624993616000},"page":"399-405","source":"Crossref","is-referenced-by-count":1,"title":["Risk Assessment of Human Papillomavirus\u2013Positive Cytology-Negative Cervical Cancer Screening in Black and White Women"],"prefix":"10.1093","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2104-4614","authenticated-orcid":false,"given":"Daniel L","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Pathology, Saint Louis University School of Medicine , St Louis, MO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelynn E","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsimar","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"White","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3273-4802","authenticated-orcid":false,"given":"Zahra","family":"Maleki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika F","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,11]]},"reference":[{"key":"2023020707505667000_CIT0001","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health."},{"key":"2023020707505667000_CIT0002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.11719","article-title":"Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost","volume":"109","author":"Yang","year":"2004","journal-title":"Int J Cancer."},{"key":"2023020707505667000_CIT0003","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin."},{"key":"2023020707505667000_CIT0004","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","article-title":"Trends in human papillomavirusM\u2013associated cancers\u2014United States, 1999-2015","volume":"67","author":"Van Dyne","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2023020707505667000_CIT0005","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers","author":"Clarke","year":"2019;37:1895-1908","journal-title":"J Clin Oncol"},{"key":"2023020707505667000_CIT0006"},{"key":"2023020707505667000_CIT0007","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.amepre.2019.12.003","article-title":"Human papillomavirus 16\/18-associated cervical lesions: differences by area-based measures of race and poverty","volume":"58","author":"Brackney","year":"2020","journal-title":"Am J Prev Med."},{"key":"2023020707505667000_CIT0008","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.5888\/pcd16.190030","article-title":"Personal and neighborhood attributes associated with cervical and colorectal cancer screening in an urban African American population","volume":"16","author":"Buehler","year":"2019","journal-title":"Prev Chronic Dis."},{"key":"2023020707505667000_CIT0009","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ypmed.2019.04.010","article-title":"Trends in cervical cancer incidence rates by age, race\/ethnicity, histological subtype, and stage at diagnosis in the United States","volume":"123","author":"Islami","year":"2019","journal-title":"Prev Med."},{"key":"2023020707505667000_CIT0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1552-6909.12488","article-title":"Barriers to cervical cancer screening and follow-up care among black women in Massachusetts","volume":"43","author":"Nolan","year":"2014","journal-title":"J Obstet Gynecol Neonatal Nurs."},{"key":"2023020707505667000_CIT0011","article-title":"Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010","volume":"3:51","author":"O\u2019Keefe","year":"2015","journal-title":"Front Public Health"},{"key":"2023020707505667000_CIT0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.15585\/mmwr.mm6608a1","article-title":"Cancer screening test use\u2014United States, 2015","volume":"66","author":"White","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2023020707505667000_CIT0013","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41598-018-36638-z","article-title":"Understanding of risk factors for the human papillomavirus (HPV) infection based on gender and race","volume":"9","author":"Osazuwa-Peters","year":"2019","journal-title":"Sci Rep."},{"key":"2023020707505667000_CIT0014","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/cncy.22316","article-title":"Health disparities in cervical cancer: prevalence of high-risk HPV and cytologic diagnoses according to race","volume":"128","author":"Miller","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"2023020707505667000_CIT0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2023020707505667000_CIT0016","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/LGT.0b013e31829f2171","article-title":"Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II\/III studies","volume":"18","author":"Goodrich","year":"2014","journal-title":"J Low Genit Tract Dis."},{"key":"2023020707505667000_CIT0017","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/bjc.2017.309","article-title":"HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test","volume":"117","author":"Polman","year":"2017","journal-title":"Br J Cancer."},{"key":"2023020707505667000_CIT0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ajcp\/aqz156","article-title":"Human papillomavirus (HPV) 16 and 18\/45 genotyping-directed follow-up of women with messenger RNA HPV-positive, cytology-negative cervical screening test results","volume":"153","author":"Han","year":"2020","journal-title":"Am J Clin Pathol."},{"key":"2023020707505667000_CIT0019","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cncy.22180","article-title":"Prevalence of HPV-16\/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing","volume":"127","author":"Tao","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"2023020707505667000_CIT0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jasc.2015.03.001","article-title":"Prevalence of HPV 16\/18 genotypes and histopathologic follow-up outcomes in women with negative cytology and positive high-risk HPV test results","volume":"4","author":"Woodard","year":"2015","journal-title":"J Am Soc Cytopathol."},{"key":"2023020707505667000_CIT0021","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA."},{"key":"2023020707505667000_CIT0022","author":"Healthy People 2030"},{"key":"2023020707505667000_CIT0023","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1377\/hlthaff.2017.1252","article-title":"Integrating data on social determinants of health into electronic health records","volume":"37","author":"Cantor","year":"2018","journal-title":"Health Aff (Millwood)."},{"key":"2023020707505667000_CIT0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12885-019-5583-7","article-title":"Factors associated with low adherence to cervical cancer follow-up retest among HPV+\/cytology negative women: a study in programmatic context in a low-income population in Argentina","volume":"19","author":"Gago","year":"2019","journal-title":"BMC Cancer."},{"key":"2023020707505667000_CIT0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis."},{"key":"2023020707505667000_CIT0026","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol."},{"key":"2023020707505667000_CIT0027","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"2023020707505667000_CIT0028","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2018.12.024","article-title":"Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, \u226525\u202fyears of age, with NILM cytology","volume":"153","author":"Stoler","year":"2019","journal-title":"Gynecol Oncol."},{"key":"2023020707505667000_CIT0029","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/ijc.32669","article-title":"Approaches to triage optimization in HPV primary screening: extended genotyping and p16\/Ki-67 dual-stained cytology-Retrospective insights from ATHENA","volume":"146","author":"Stoler","year":"2020","journal-title":"Int J Cancer."},{"key":"2023020707505667000_CIT0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0969141314522219","article-title":"Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women","volume":"21","author":"Del Mistro","year":"2014","journal-title":"J Med Screen."},{"key":"2023020707505667000_CIT0031","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.2019.4595","article-title":"Cervical cancer screening: more choices in 2019","volume":"321","author":"Sawaya","year":"2019","journal-title":"JAMA."},{"key":"2023020707505667000_CIT0032","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.01087-15","article-title":"Point-counterpoint: cervical cancer screening should be done by primary human papillomavirus testing with genotyping and reflex cytology for women over the age of 25 years","volume":"53","author":"Stoler","year":"2015","journal-title":"J Clin Microbiol."},{"key":"2023020707505667000_CIT0033","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ajcp\/aqy169","article-title":"HPV testing with 16, 18, and 45 genotyping stratifies cancer risk for women with normal cytology","volume":"151","author":"Stoler","year":"2019","journal-title":"Am J Clin Pathol."},{"key":"2023020707505667000_CIT0034","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/AJCPAZV88VIFZSFD","article-title":"High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up","volume":"133","author":"Thrall","year":"2010","journal-title":"Am J Clin Pathol."},{"key":"2023020707505667000_CIT0035","article-title":"Relative performance of HPV and cytology components of cotesting in cervical screening","author":"Schiffman","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"2023020707505667000_CIT0036","doi-asserted-by":"crossref","first-page":"96","DOI":"10.23736\/S0026-4784.20.04511-6","article-title":"Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening","volume":"72","author":"Pimple","year":"2020","journal-title":"Minerva Ginecol."},{"key":"2023020707505667000_CIT0037","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/infdis\/jix333","article-title":"Modeling of US human papillomavirus (HPV) seroprevalence by age and sexual behavior indicates an increasing trend of HPV infection following the sexual revolution","volume":"216","author":"Ryser","year":"2017","journal-title":"J Infect Dis."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/157\/3\/399\/49113512\/aqab129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/157\/3\/399\/49113512\/aqab129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T11:03:50Z","timestamp":1675767830000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/157\/3\/399\/6368701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,11]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,11]]},"published-print":{"date-parts":[[2022,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqab129","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,9,11]]}}}